Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision tag v3.6.5 was added, superseding the prior v3.6.4. This indicates a minor update to the page's revision history rather than a content change.
    Difference
    0.0%
    Check dated 2026-08-08T16:43:20.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.3 to v3.6.4, indicating a minor maintenance update to the ClinicalTrials.gov record. No substantive study information appears to change.
    Difference
    0.0%
    Check dated 2026-07-25T11:39:55.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision bumped from v3.6.2 to v3.6.3, indicating a small update to the site’s revision metadata and backend; it does not alter the displayed study details or page structure.
    Difference
    0.0%
    Check dated 2026-07-04T03:52:45.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.2, replacing v3.6.0, indicating a newer version of the study page content and metadata. This appears to be a minor technical update rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-06-26T19:48:22.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Recruitment status updated to not actively recruiting and enrollment updated to 70 participants. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the study timeline was updated to show primary completion on 2027-12-31 and study completion on 2030-12-31.
    Difference
    1%
    Check dated 2026-06-12T13:37:07.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, reflecting a minor update to the page metadata. The change represents an internal update to the ClinicalTrials.gov entry rather than a modification to the study content or results.
    Difference
    0.0%
    Check dated 2026-06-05T08:29:44.000Z thumbnail image

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.